Similarly, genes identified as targets of ALL components of PRC1 and PRC2 were enriched (1.6 to 2.2-fold) in the genes showing a positive DNA methylation response to SIRT1. The gene discussed is SIRT1; the disease is acute lymphoblastic leukemia.